Traduction de «potential and access » (Anglais → Français) :

A Step-by-step Kit for Accessing Information on Federal Government Programs and Services for Exporters and Potential Exporters

accession to the European Union [ accession to the Community | act of accession | application for accession | consequence of accession | EU accession | request for accession ]

event-related potentials | ERPs | event-related brain potentials | endogenous evoked potentials | endogenous potentials | cognitive evoked potentials | cognitive potentials | Events Related Potentials

potential GDP | potential gross domestic product | potential output | potential production

corrosion potential | rest potential | freely corroding potential | compromise potential | free corrosion potential

breakdown potential | critical breakdown potential | critical pitting potential | pitting potential | rupture potential

pre-accession aid [ Instrument for Pre-Accession Assistance | Instrument for Structural Policies for Pre-Accession | IPA | ISPA | Phare | pre-accession assistance | Pre-Accession Instrument | Sapard ]

oxidation-reduction potential [ oxidation reduction potential | redox potential | oxydoreduction potential ]

visually evoked cortical potential [ VECP | visual evoked cortical potential | visual evoked response | visually evoked potential | visual evoked potential | visually evoked response ]

accession to an agreement [ accession to a convention | accession to a treaty | signatures, accessions, ratifications(UNBIS) ]

To exploit the full potential of access to a growing international LNG market and to make the EU an attractive market for suppliers the EU needs to do three things:

Regrets that it is still difficult for citizens to gain access to information held by EU institutions, the reason being that there is no common approach among the institutions geared to facilitate access to documents for citizens and based on complete transparency, communication and direct democracy; urges the EU institutions, bodies, offices and agencies to develop further a more proactive approach on transparency by proactively disclosing as many of their documents as possible, in the most simple, user-friendly and accessible way, ...[+++]by having documents translated upon request into other EU official languages, and by establishing proper, simple and inexpensive information access arrangements, including by digital and electronic means, allowing for the needs of people with disabilities; considers, in particular, that the accessibility of information should be improved on by means of easy-to-use interfaces and search systems; calls for the development of a common access point to the portals of the three institutions, building on the pilot project for the online platform for the proactive publication of EU institutions documents, and for harmonising search portals between departments of the same institution (including Directorates-General in the Commission); calls, as well, on the institutions to continue and strengthen the work of expanding knowledge of EU legislation and policies; believes that, to that end, the EU should make full use of the potential offered by new technologies (social networks, smartphone applications, etc.) in order to ensure complete and easy access to information.

There is a need to use the potential of accessibility for the internal market since it will enhance transnational mobility in Europe while facilitating the mobility of workers and persons with disabilities.

CONSIDERING that multinational clinical research is currently hampered by the fragmentation of health and legislative systems in Europe, an obstacle for multinational cooperation in investigator driven, as well as industry-sponsored clinical research (particularly in the biotechnology and medical device sectors), European countries must unlock latent scientific potential and access to patients and expertise, thus strengthening the competitiveness of Europe in clinical science and its attractiveness for the development of preventive, diagnostic and therapeutic procedures — this is of particular importance for rare diseases, paediatrics, p ...[+++]ersonalised treatments, for the development of biotherapy, and for independent clinical trials that are pivotal instruments for evidence-based medicine;